Wednesday, January 27, 2021 12:45:05 PM
https://stockmarketrevolution.com/archives/15457
With more than 1500% stock returns in 2020 and 2021, Enzolytics Inc. (ENZC) continues to amaze the investment community. The company owns licensing rights of the Irreversible Pepsin Fraction peptide molecule, a new treatment of HIV/AIDS. Currently at a clinical stage, Enzolytics has made an investment in an european entity, which is conducting trials to prove the new treatment. Given the stock returns, many traders seem to believe that the results will be a success.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
- MWRK Positions For High Growth In $3.5 Trillion Metaverse Market Popularized By META • InvestorsHub NewsWire • 05/03/2023 04:24:58 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM